Sharing Clinical Data that Identifies Gut Microbiota Biomarkers Associated with Improved Clinical Response in Alzheimer’s Disease Patients Treated with ANAVEX®2-73

Time: 11:30 am
day: Day Two


• Linking high-levels of two gut microbiota families to improved responses with ANAVEX®2-73
• Outlining how and why ANAVEX®2-73 may have a beneficial homeostatic effect on brain-gut microbiota axis